Exhibit 3(p)


                           AMENDMENT TO BYLAWS OF
                         K-V PHARMACEUTICAL COMPANY

As directed by the unanimously adopted resolution of the Board of Directors
of K-V Pharmaceutical Company duly adopted on June 28, 2004, the Bylaws of
the Company were amended, effective September 9, 2004 (the date of the
Annual Meeting of Shareholders held on such date), by amending the first
sentence of Article III, Section 1 thereof to read as follows in its
entirety:

     "The number of directors which shall constitute the whole board shall
be nine."